NDC 24338-080-25 - OTOVEL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24338-080
- Requested NDC
- 24338-080-25
- Package NDCs from labels
- 24338-080-25, 24338-080-14
- Manufacturer
- Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation
- Effective date
- 2019-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OTOVEL - Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation | Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation | 2019-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24338-080-14 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-ec5a-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use OTOVEL safely and effectively. See full prescribing information for OTOVEL. OTOVEL (ciprofloxacin and fluocinolone acetonide) otic solution Initial U.S. Approval: 2016 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24338-080-14 | OTOVEL | 14 in 1 POUCH | SOLUTION | 14 | 3 | |
| 24338-080-14 | OTOVEL | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 24338-080-25 | OTOVEL | 0.25 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 0.25 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Hemorrhoidal Cream with Aloe | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Chain Drug Marketing Association | 2b33c710-ac17-20f9-e063-6294a90ad29c | 2025-01-08 | Warnings | PDC6A3C0OX |
| ANTIBACTERIAL DREAMY FLORALS | GLYCERIN | Quimicas Handal de Centroamerica SA de CV | 09f73bec-516d-90f0-e063-6394a90aecab | 2025-01-08 | Warnings | PDC6A3C0OX |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Prevention Oncology Mouth Rinse | GLYCERIN | Prevention Health Sciences, Inc. | 1ec9ed1c-bcb6-3a0a-e054-00144ff8d46c | 2025-01-01 | Warnings | PDC6A3C0OX |
| CLENZIDERM THERAPEUTIC MOISTURIZER | GLYCERIN | Obagi Cosmeceuticals LLC | d60e22e3-831e-4787-a82c-e7763c287553 | 2025-01-01 | Warnings | PDC6A3C0OX |
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Fendall Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | afda6fc3-7615-b0be-e053-2995a90a6208 | 2024-12-10 | Warnings | 059QF0KO0R |
| Burts Bees Rapid Rescue Cold Sore Treatment | CAMPHOR, GLYCERIN | Burts Bees | 9f89735d-205f-4d3e-a1e1-ecc96284fe98 | 2024-12-03 | Warnings | PDC6A3C0OX |
| PhysiciansCare Ophthalmic Solution Eyewash Purified Water, 98.3% | PURIFIED WATER 98.3% | Acme United Corporation | 9248ee71-2d47-620d-e053-2995a90af5c8 | 2024-11-26 | Warnings | 059QF0KO0R |
| PhysiciansCare Ophthalmic Solution Eyewash | PURIFIED WATER 98.3% | Acme United Corporation | cca454e0-b2bd-4215-bc06-426fcc3f7bd6 | 2024-11-26 | Warnings | 059QF0KO0R |
| PhysiciansCare Ophthalmic Solution Eyewash | PURIFIED WATER 98.3% | Acme United Corporation | d3812fa3-9334-464d-b50c-98548ff76727 | 2024-11-26 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.